Schaap N - Search Results

1

Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.

Koenecke C, Göhring G, de Wreede LC, van Biezen A, Scheid C, Volin L, Maertens J, Finke J, Schaap N, Robin M, Passweg J, Cornelissen J, Beelen D, Heuser M, de Witte T, Kröger N; MDS subcommittee of the Chronic Malignancies Working Party of the EBMT. Koenecke C, et al. Among authors: schaap n. Haematologica. 2015 Mar;100(3):400-8. doi: 10.3324/haematol.2014.116715. Epub 2014 Dec 31. Haematologica. 2015. PMID: 25552702 Free PMC article.

2

Massive pleural effusion attributed to high-dose cyclophosphamide during conditioning for BMT.

Schaap N, Raymakers R, Schattenberg A, Ottevanger JP, de Witte T. Schaap N, et al. Bone Marrow Transplant. 1996 Jul;18(1):247-8. Bone Marrow Transplant. 1996. PMID: 8832029

3

Outcome of allogeneic bone marrow transplantation with lymphocyte-depleted marrow grafts in adult patients with myelodysplastic syndromes.

Mattijssen V, Schattenberg A, Schaap N, Preijers F, De Witte T. Mattijssen V, et al. Among authors: schaap n. Bone Marrow Transplant. 1997 Apr;19(8):791-4. doi: 10.1038/sj.bmt.1700739. Bone Marrow Transplant. 1997. PMID: 9134170 Free article.

4

Survival in first or second remission after lymphocyte-depleted transplantation for Philadelphia chromosome-positive CML in first chronic phase.

Schattenberg A, Preijers F, Mensink E, Bär B, Schaap N, Geurts van Kessel A, van der Maazen R, de Witte T. Schattenberg A, et al. Among authors: schaap n. Bone Marrow Transplant. 1997 Jun;19(12):1205-12. doi: 10.1038/sj.bmt.1700824. Bone Marrow Transplant. 1997. PMID: 9208114 Free article.

5

Outcome of transplantation for standard-risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimen.

Schaap N, Schattenberg A, Bär B, Preijers F, Geurts van Kessel A, van der Maazen R, de Boo T, de Witte T. Schaap N, et al. Br J Haematol. 1997 Sep;98(3):750-9. doi: 10.1046/j.1365-2141.1997.d01-3499.x. Br J Haematol. 1997. PMID: 9332335 Free article.

6

Idarubicin to intensify the conditioning regimens of autologous bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.

Jerjis S, Roovers E, Muus P, Schaap N, de Witte T. Jerjis S, et al. Among authors: schaap n. Bone Marrow Transplant. 1998 Jul;22(1):13-9. doi: 10.1038/sj.bmt.1701279. Bone Marrow Transplant. 1998. PMID: 9678790 Clinical Trial.

7

Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR.

Mensink E, van de Locht A, Schattenberg A, Linders E, Schaap N, Geurts van Kessel A, De Witte T. Mensink E, et al. Among authors: schaap n. Br J Haematol. 1998 Aug;102(3):768-74. doi: 10.1046/j.1365-2141.1998.00823.x. Br J Haematol. 1998. PMID: 9722305 Free article.

8

In relapsed patients after lymphocyte depleted bone marrow transplantation the percentage of donor T lymphocytes correlates well with the outcome of donor leukocyte infusion.

Schattenberg A, Schaap N, Van De Wiel-Van Kemenade E, Bär B, Preijers F, Van Der Maazen R, Roovers E, De Witte T. Schattenberg A, et al. Among authors: schaap n. Leuk Lymphoma. 1999 Jan;32(3-4):317-25. doi: 10.3109/10428199909167392. Leuk Lymphoma. 1999. PMID: 10037029 Clinical Trial.

9

Cost analysis of autologous peripheral stem cell transplantation versus autologous bone marrow transplantation for patients with non Hodgkin's lymphoma and acute lymphoblastic leukaemia.

Jerjis S, Croockewit S, Muus P, Schaap N, Preijers F, de Witte T. Jerjis S, et al. Among authors: schaap n. Leuk Lymphoma. 1999 Dec;36(1-2):33-43. doi: 10.3109/10428199909145947. Leuk Lymphoma. 1999. PMID: 10613448

10

Red blood cell phenotyping is a sensitive technique for monitoring chronic myeloid leukaemia patients after T-cell-depleted bone marrow transplantation and after donor leucocyte infusion.

Schaap N, Schattenberg A, Bär B, Mensink E, de Man A, Geurts van Kessel A, de Witte T. Schaap N, et al. Br J Haematol. 2000 Jan;108(1):116-25. doi: 10.1046/j.1365-2141.2000.01803.x. Br J Haematol. 2000. PMID: 10651734 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

159 results

Search Page